作者:David J. Rawson、Delphine Brugier、Anthony Harrison、Jo Hough、Julie Newman、Joe Otterburn、Graham N. Maw、Jenny Price、Lisa R. Thompson、Paul Turnpenny、Andrew N. Warren
DOI:10.1016/j.bmcl.2011.04.058
日期:2011.6
A potent series of substituted (2S,4S)-benzylproline alpha(2)delta ligands have been designed from the readily available starting material (2S,4R)-hydroxy-L-proline. The ligands have improved pharmacokinetic profile over the (4S)-phenoxyproline derivatives described previously and have potential for development as oral agents for the treatment of neuropathic pain. Compound 16 has been progressed to clinical development. (C) 2011 Elsevier Ltd. All rights reserved.